The Oncologist, Vol. 8, No. 2, 174186,
April 2003
© 2003 AlphaMed Press
ORIGINAL PAPER Pediatric Oncology |
Advances in the Diagnosis, Molecular Genetics, and Treatment of Pediatric Embryonal CNS Tumors
Tobey J. MacDonalda,
Brian R. Rooda,
Maria R. Santib,
Gilbert Vezinac,
Kimberly Bingamand,
Philip H. Cogend,
Roger J. Packere
a Departments of Hematology/Oncology,
b Pathology,
c Radiology,
d Neurosurgery, and
e Neurology, Childrens Hospital National Medical Center, Washington, DC, USA
Correspondence:
Tobey J. MacDonald, M.D., Childrens Hospital National Medical Center, Department of Hematology/Oncology, 111 Michigan Avenue, NW, Washington, DC 20010, USA. Telephone: 202-884-2800; Fax: 202-884-5685; e-mail: tmacdona{at}cnmc.org
Embryonal central nervous system (CNS) tumors are the most common group of malignant brain tumors in children. The diagnosis and classification of tumors belonging to this family have been controversial; however, utilization of molecular genetics is helping to refine traditional histopathologic and clinical classification schemes. Currently, this group of tumors includes medulloblastomas, supratentorial primitive neuroectodermal tumors, atypical teratoid/rhabdoid tumors, ependymoblastomas, and medulloepitheliomas. While the survival of older children with nonmetastatic medulloblastomas has improved considerably within the past two decades, the outcomes for infants and for those with metastatic medulloblastomas or other high-risk embryonal CNS tumors remain poor. It is anticipated that the emerging field of molecular biology will greatly aid in the future stratification and therapy for pediatric patients with malignant embryonal tumors. In this review, recent advances in the diagnosis, molecular genetics, and treatment of the most common pediatric embryonal CNS tumors are discussed.
Key Words. Primitive neuroectodermal tumor • Medulloblastoma • Atypical teratoid/rhabdoid tumor • Diagnosis • Molecular genetics • Treatment
This article has been cited by other articles:

|
 |

|
 |
 
T. Shalaby, A. O. von Bueren, M.-L. Hurlimann, G. Fiaschetti, D. Castelletti, T. Masayuki, K. Nagasawa, A. Arcaro, I. Jelesarov, K. Shin-ya, et al.
Disabling c-Myc in Childhood Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor Cells by the Potent G-Quadruplex Interactive Agent S2T1-6OTD
Mol. Cancer Ther.,
January 1, 2010;
9(1):
167 - 179.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Packer and G. Vezina
Management of and Prognosis With Medulloblastoma: Therapy at a Crossroads
Arch Neurol,
November 1, 2008;
65(11):
1419 - 1424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. MacDonald
Aggressive Infantile Embryonal Tumors
J Child Neurol,
October 1, 2008;
23(10):
1195 - 1204.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. de Bont, J. M. Kros, M. M.C.J. Passier, R. E. Reddingius, P. A.E. S. Smitt, T. M. Luider, M. L. d. Boer, and R. Pieters
Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis
Neuro Oncology,
October 1, 2008;
10(5):
648 - 660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Vibhakar, G. Foltz, J.-g. Yoon, L. Field, H. Lee, G.-y. Ryu, J. Pierson, B. Davidson, and A. Madan
Dickkopf-1 is an epigenetically silenced candidate tumor suppressor gene in medulloblastoma
Neuro Oncology,
April 1, 2007;
9(2):
135 - 144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Packer, A. Gajjar, G. Vezina, L. Rorke-Adams, P. C. Burger, P. L. Robertson, L. Bayer, D. LaFond, B. R. Donahue, M. H. Marymont, et al.
Phase III Study of Craniospinal Radiation Therapy Followed by Adjuvant Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma
J. Clin. Oncol.,
September 1, 2006;
24(25):
4202 - 4208.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tsikitis, Z. Zhang, W. Edelman, D. Zagzag, and G. V. Kalpana
Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss
PNAS,
August 23, 2005;
102(34):
12129 - 12134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. D. Hemmati, I. Nakano, J. A. Lazareff, M. Masterman-Smith, D. H. Geschwind, M. Bronner-Fraser, and H. I. Kornblum
Cancerous stem cells can arise from pediatric brain tumors
PNAS,
December 9, 2003;
100(25):
15178 - 15183.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by AlphaMed Press.
|
|